Page tree
Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 46 Next »



Overview

This use case involves patients identifying clinical trials for which they may be eligible for via a tool directly accessible to them. With this tool, patients can leverage structured patient data from their electronic health record (EHR) and structured descriptions of clinical trial eligibility criteria to assess matches. The patient is then able to view a list of clinical trials in which they may be eligible to enroll. 


EPFCT Details

ActorCancer patient. 
Description

A cancer patient identifies clinical trials for which she may be eligible. She uses tools that she can access directly, and she does not have to do manual transcription of clinical data. Rather, the tool leverages structured patient data from the electronic health record (EHR) and structured descriptions of clinical trial eligibility criteria to assess matches.

Trigger

Patient wants to identify clinical trials for which she meets the eligibility criteria to enroll.

Preconditions
  • Required patient data exists in a structured computable format
  • Patient has access to use clinical trial matching tool
Postconditions

Patient views a list of clinical trials in which she may be eligible to enroll.

Extensions

What if there are no matching clinical trials?

Assumptions

What do we accept to be true? May need to be validated by partners.

ScopeThis use case addresses patients finding clinical trials. Providers use of the clinical trial matching tool on behalf of their patients is covered in a separate use case. 
Notes

ACS CAN is involved in a workgroup that is analyzing which data elements are most impactful for capturing trial eligibility criteria. Candidate elements include:

  • Diagnosis (primary)
  • Diagnosis (secondary subtype/histology)
  • Tumor Stage
  • Metastatic status and location
  • Biomarkers (options may vary by cancer type)
  • Performance status
  • Prior/concurrent malignancy
  • Immune function /viral infection status (Hepatitis, HIV)



Conference Call Information

Important Dates

EventDate/Time






Use Case Team

RoleNameOrganizationEmail
Domain LeadAmmu IrivintiThe MITRE Corporation

sirivinti@mitre.org 

Domain LeadSalim SemyThe MITRE Corporation

ssemy@mitre.org 







  • No labels